These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Plasmapheresis treatment in multiple myeloma with kidney insufficiency]. Blumberg A; Bürgi W; Marti HR Schweiz Med Wochenschr; 1983 Mar; 113(11):398-402. PubMed ID: 6844898 [TBL] [Abstract][Full Text] [Related]
3. Advances in the diagnosis and management of myeloma. Greipp PR Semin Hematol; 1992 Jul; 29(3 Suppl 2):24-45. PubMed ID: 1509293 [No Abstract] [Full Text] [Related]
4. [Plasmapheresis in the therapy of the hyperosmolar syndrome in patients with myelomatous nephropathy]. Borisov AV; Butrov AV; Moroz VA Ter Arkh; 1991; 63(7):101-5. PubMed ID: 1788784 [No Abstract] [Full Text] [Related]
5. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Johnson WJ; Kyle RA; Pineda AA; O'Brien PC; Holley KE Arch Intern Med; 1990 Apr; 150(4):863-9. PubMed ID: 2183734 [TBL] [Abstract][Full Text] [Related]
6. [Therapy of multiple myeloma and its complications]. Avvisati G; Pulsoni A; Petrucci MT; Tribalto M Recenti Prog Med; 1990 Oct; 81(10):642-50. PubMed ID: 2291008 [TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of multiple myeloma. Review of the recent trials]. Tribalto M; Arcese W; Colombo R; Pastore S; Franchii A Recenti Prog Med; 1981 Aug; 71(2):141-7. PubMed ID: 7031807 [No Abstract] [Full Text] [Related]
9. Multiple myeloma. Progress is being made. Mayo Clin Health Lett; 2011 Mar; 29(3):4-5. PubMed ID: 21553706 [No Abstract] [Full Text] [Related]
10. [The treatment of osseous multiple myeloma; possible value of plasmapheresis]. Revol L; Favre-Gilly J; Bryon PA; Guyon M; Fiere D Lyon Med; 1972 May; 227(10):901-3. PubMed ID: 5053536 [No Abstract] [Full Text] [Related]
11. Therapeutic plasmapheresis in patients with renal disease. Morse EE; Pisciotto PT Ann Clin Lab Sci; 1981; 11(4):361-6. PubMed ID: 7196721 [TBL] [Abstract][Full Text] [Related]
12. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient. Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480 [TBL] [Abstract][Full Text] [Related]
13. [Therapeutic experiences in multiple myeloma]. Sonntag R; Favre E; Martz G Schweiz Med Wochenschr; 1972 Nov; 102(44):1588-9. PubMed ID: 4566555 [No Abstract] [Full Text] [Related]
14. [New suggestions for the treatment of plasmacytoma in the light of modern pathogenetic concepts]. Anisimowicz J Acta Haematol Pol; 1977; 8(4):325-31. PubMed ID: 146999 [No Abstract] [Full Text] [Related]
15. [Prognostic factors in multiple myeloma]. Boccadoro M; Bianchi A; Dianzani U; Frieri R; Gallone G; Massaia M; Omede P; Palumbo A; Pileri A Haematologica; 1989 Oct; 74(5 Suppl):347-57. PubMed ID: 2512219 [No Abstract] [Full Text] [Related]
16. [Progress and results in the treatment of multiple myeloma]. Clauvel JP Bull Cancer; 1972; 59(4):405-16. PubMed ID: 4592093 [No Abstract] [Full Text] [Related]
17. [Treatment of myeloma disease]. Verevkin IN Med Sestra; 1981 Nov; 40(11):5-7. PubMed ID: 6915349 [No Abstract] [Full Text] [Related]
18. Peritoneal dialysis in the treatment of renal failure in multiple myeloma. Yium J; Martinez-Maldonado M; Eknoyan G; Suki WN South Med J; 1971 Nov; 64(11):1403-5. PubMed ID: 5134479 [No Abstract] [Full Text] [Related]
19. Dosing chemotherapy agents in hemodialysis--a focus on multiple myeloma. Runnels R; Cameron K; Ng P; Battistella M CANNT J; 2014; 24(1):21-5; quiz 26-7. PubMed ID: 24783769 [No Abstract] [Full Text] [Related]
20. Clinical utilization of plasmapheresis and cyclophosphamide in the treatment of malignant lymphoproliferative processes. Sakalová A; Gazová S; Hrubisko M; Gáliková J Neoplasma; 1973; 20(3):335-9. PubMed ID: 4199115 [No Abstract] [Full Text] [Related] [Next] [New Search]